Clinical Trial Update: A Study of Nociceptin/Orphanin FQ Peptide Receptor Occupancy in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating occupancy of the nociceptin/orphanin FQ peptide receptor in healthy subjects; the trial sponsored by BlackThorn Therapeutics for depres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: BlackThorn Therapeutics, Inc. | Conditions: Depression | Phase 1 | Status: COMPLETED